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ABSTRACT 
 
Harmful materials are released into the environment during emergencies and 
disasters. These materials pose a risk to animals involved in search and rescue efforts 
without the benefit of personal protective equipment.  Search and Rescue (S&R) canines 
are often decontaminated multiple times during deployments to limit their potential 
exposure to toxic or harmful substances they come into contact with.  Consecutive 
decontamination has the potential to induce epidermal irritation, decrease the natural 
protections associated with a healthy dermis and thereby increase the risk of absorption 
and internalization of hazardous material. 
The focus of this study was to evaluate the efficacy of two soap products in the 
removal of oil-based contaminants and to determine the subsequent likelihood of 
inducing epidermal irritation and transepidermal water loss when used serially over a 
standard 14-day deployment.  
The results of this study revealed that Dawn® Ultra is more effective than 
DermaLyte® at removing oil-based contaminants.  The serial use of each of these 
products resulted in mild to moderate epidermal irritation within 4.9 to 15.8 days for 
Dawn® soap and 5.8 to 21.4 days for DermaLyte® soap.  Transepidermal water loss did 
not quantify or predict visibly scored epidermal irritation.  These results will guide the 
development of S&R dog decontamination protocols. 
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NOMENCLATURE 
 
CI Confidence Interval 
CADESI Canine Atopic Dermatitis Extent and Severity Index  
PPE Personal Protective Equipment 
TEWL Transepidermal Water Loss  
S&R Search & Rescue 
 vi 
 
TABLE OF CONTENTS 
Page 
ABSTRACT ..................................................................................................................     ii 
DEDICATION .............................................................................................................     iii 
ACKNOWLEDGEMENTS ..........................................................................................    iv 
NOMENCLATURE .....................................................................................................      v 
TABLE OF CONTENTS ..............................................................................................    vi 
LIST OF FIGURES ......................................................................................................   viii 
LIST OF TABLES ........................................................................................................    ix 
INTRODUCTION ........................................................................................................      1 
LITERATURE REVIEW .............................................................................................      4 
Introduction ..............................................................................................................      4 
Search & Rescue Canines ........................................................................................      4 
Exposures during Disasters for Search & Rescue Canines ......................................      5 
Canine External Decontamination ...........................................................................      6 
Canine Decontamination Challenges .......................................................................      7 
Conclusion ................................................................................................................    13 
Objectives and Aims ................................................................................................    13 
Hypothesis ................................................................................................................    13 
MATERIALS AND METHODS .................................................................................    15 
Sample Size ..............................................................................................................    15 
Animals ....................................................................................................................    16 
Washout Period ........................................................................................................    19 
Canine Decontamination Protocol ...........................................................................    20 
Epidermal Evaluations .............................................................................................    22 
Transepidermal Water Loss .....................................................................................    23 
Statistical Analysis ...................................................................................................    23 
Canine Decontamination ???? ??????...........................................................................     20
???????????? ????????? ............................................................................................     22
 vii 
 
Epidermal Irritation ..................................................................................................    26 
Time to Event for Visual Dermatological Effect Indices .........................................    30 
Transepidermal Water Loss .....................................................................................    31 
DISCUSSION ..............................................................................................................    33 
Study Limitations .....................................................................................................    35 
SUMMARY AND CONCLUSIONS ...........................................................................    40 
REFERENCES .............................................................................................................    41 
APPENDIX A ..............................................................................................................    44 
APPENDIX B ..............................................................................................................    45 
APPENDIX C ..............................................................................................................    49 
APPENDIX D ..............................................................................................................    50 
APPENDIX E ...............................................................................................................    51 
 
 
   
 
 
 
 
RESULTS .....................................................................................................................    26 
Effectiveness of a High and Low Anionic Soap ......................................................    26 
 viii 
 
LIST OF FIGURES 
FIGURE Page 
1      Rapid Pro K9 Decontamination Station ................................................................     9 
2      Companion Animal Decontamination Unit ...........................................................   21 
3      Erythema Occurrences by Location with DermaLyte® Exposure ........................   27 
4      Erythema Occurrences by Location with Dawn®  Exposure ...............................   28 
5      Excoriation Occurrences by Location with DermaLyte® Exposure .....................   28 
6      Excoriation Occurrences by Location with Dawn®  Exposure ............................   29 
7      Participant Withdrawal From Study as a Result of Moderate Epidermal        
Irritation Participant Withdrawal .........................................................................   30 
 
 ix 
 
LIST OF TABLES 
TABLE Page 
 
1      General Toxicological Hazards for S&R Canines ................................................     6 
2      Types of Surfactants ..............................................................................................   11 
3      Results of Simulated Datasets ...............................................................................   15 
4      Trial 1 Study Design .............................................................................................   17 
5      Trial 2 Study Design .............................................................................................   18 
6      Trial 3 Study Design .............................................................................................   19 
7      Median Number of Washes ...................................................................................   26 
8      Median ml of Soap ................................................................................................   26 
9      Expected Median Time (days) for Severity Occurrence .......................................   30 
10    Median Relative Daily Risk for TEWL ................................................................   31 
11    Median TEWL Relative Risk Between Treatment Groups ...................................   32 
12    Standard Deviation of Collection Days, Dog, & Collection Location ..................   32 
 
 
 1 
 
INTRODUCTION 
 
Natural disasters and emergencies are all too frequent realities.  Search and 
Rescue (S&R) dogs play a critical role locating individuals who have become lost, 
displaced, injured, or victims during these incidents.  S&R canines are effective assets 
for human detection; however, there are calculated risks associated with deploying 
canines into hazardous environments (Migala and Brown 2012). During searches, 
working canines commonly come into contact with materials and substances that could 
potentially possess hazardous, toxic, biological, or radioactive properties (Chan et al. 
2013, Gwaltney-Brant et al. 2003).  Exposure to these materials has the potential to 
result in direct health complications for the animal. 
Disaster situations often result in the intentional or unintentional release of 
hazardous materials into the environment (Young, Balluz and Malilay 2004).   The 
Agency of Toxic Substances and Disease Registry estimated that, in 2012, more than 
15,000 chemical incidents occurred in the United States (Agency for Toxic Substances 
and Disease Registry).  In addition to industrial accidents, disasters such as the World 
Trade Center terrorist attack, Hurricane Katrina, and the West, Texas explosion all 
resulted in the release of hazardous materials into the environment.  In addition to the 
debris created, the destruction of the World Trade Center resulted in substantial amounts 
of asbestos, polycyclic aromatic hydrocarbons, metal compounds, dioxins, and volatile 
organic compounds liberated in the wreckage (Banauch, Dhala and Prezant 2005).  The 
 2 
 
flooding associated with Hurricane Katrina led to the mixture of hazardous materials 
from damaged chemical plants, petroleum refining facilities, and commercial 
establishments into the environment (Reible et al. 2006).  The fertilizer explosion in 
West, Texas resulted in the spread of ammonium nitrate into the surrounding area 
(Pittman et al. 2014). In each of these situations, the introduction of hazardous materials 
into areas occupied by survivors, S&R teams, and resident animals created a significant 
risk to human and animal health. 
The use of canines to search in contaminated areas can result in internal and 
external contamination of the dogs.  External contamination occurs when hazardous 
materials come into contact with an animal’s skin or hair coat, while internal 
contamination arises when materials are introduced into the body through absorption, 
ingestion, or inhalation (Murphy 2011).  Regardless of type, the presence of 
contaminants may result in potential health complications. To mitigate both the exposure 
to and potential health consequences from contaminants, frequent decontamination is 
performed on search canines throughout a deployment period (Murphy 2011).   
Decontamination is the process of removing contaminants from people, animals, 
equipment, structures, and the environment (Kumar et al. 2010).  Decontamination 
protocols are devised to eliminate exposures to hazardous materials and reduce the 
spread of contamination.  Mechanisms utilized in decontamination include: physical 
removal, solvation, emulsification, chemical alteration, absorption, adsorption, and 
friction (Chan et al. 2013). 
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While decontamination is currently utilized to reduce S&R canines’ exposure to 
contaminants, there are many challenges associated with this process including efficacy, 
safety, and frequency of decontamination.  As a result, the remainder of this manuscript 
will focus on external decontamination of S&R canines exposed to oil-based 
contaminants in a simulated disaster situation.  
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LITERATURE REVIEW 
 
Introduction 
Emergency and disaster situations result in an increased risk for release of 
hazardous materials into the environment and subsequent exposure to these 
contaminants by victims and first responders.  Decontamination protocols for humans 
are well defined and reviewed.  Animal decontamination protocols are less defined and 
primarily based on anecdotal evidence. This knowledge gap is particularly important for 
canine first responders as they are at an increased risk for exposure to hazardous 
materials due to the lack of protective equipment.  It has been assumed that these dogs 
will require daily decontamination throughout a response period (Gordon 2012). 
Search & Rescue Canines 
For the past 200 years, Search & Rescue (S&R) canines have been a critical asset 
in the assistance of human detection (Jones et al. 2004).  It is well documented that 
canines surpass human’s ability to effectively search areas (Migala and Brown 2012).  
Canines not only have the ability to locate individuals based on their sense of smell, but 
also are able to search and work within confined spaces more effectively than their 
human counterparts (Jones et al. 2004).  The ability for canines to work efficiently has 
been proven across multiple deployments including the Bastrop Complex Wildfires of 
2011, as six canines searched a total of 15,598 acres of structures in five days (Migala 
and Brown 2012). 
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Although S&R canines are viewed as a critical partner in human detection during 
disaster situations, deployable S&R dogs have been known to have an elevated health 
risk associated with responding to disaster when compared to their human counterparts 
(Migala and Brown 2012).  All human first responders normally wear Personal 
Protective Equipment (PPE) to ensure their safety and prevent exposure to possible 
unknown hazardous materials during a disaster response (Wenzel 2007).  Canines 
however cannot wear PPE, nor have any additional protection against natural hazards, 
man-made hazards, or toxic chemicals  (Gwaltney-Brant et al. 2003). 
Exposures during Disasters for Search & Rescue Canines 
 The inadvertent or accidental introduction of hazardous materials into the 
environment during an emergency or disaster can contaminate victims, animals, and first 
responders. Contamination on-site during a disaster or emergency can increase the 
likelihood of S&R canines becoming exposed (Gwaltney-Brant et al. 2003).  Exposures 
may include a wide range of hazardous materials such as biological fluids and tissues, 
industrial and household chemicals, petroleum products, and radioactive substances 
(Leary et al. 2014).  A report on the general toxicological hazards and risks for S&R 
canines responding to urban disasters (Table 1) revealed a large diversity of hazards that 
canines can potentially be exposed to while searching collapsed buildings (Gwaltney-
Brant et al. 2003).   
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Table 1: General Toxicological Hazards for S&R Canines 
Physical Form Type of Exposures Examples 
Solids & 
Liquids 
Ingestion, Inhalation, Dermal, 
Ocular 
Hydrocarbons, Polychlorinated 
Biphenyls, toxic metals, Acids, 
Alkalis, Glycols, Phenols, 
Alcohols 
Particulates  Inhalation, Dermal, Ocular Fiberglass, Asbestos particles, 
Mold Spores, Hydrocarbons, 
Glycols, Nontoxic Dust 
Gases Inhalation Hydrogen Cyanide, Nitrogen 
Dioxide, Hydrogen Chloride, 
Hydrogen Fluoride, 
Hydrogen Bromide  
(Gwaltney-Brant et al. 2003) 
  
 
 
The consequences associated with working in areas that contain hazardous 
substances and the concurrent lack of protection present serious health concerns for 
canines and thus require decontamination for mitigation (Murphy et al. 2003). 
Canine External Decontamination 
 There are anecdotal protocols designed for veterinary clinics and disaster 
situations based on a single contaminant incident. In current literature, animal 
decontamination protocols are based on the basic principles of leading animals through 
multiple stations involving the removal of contaminated articles (halters, collars, 
leashes), washing and rinsing the animal, and finally drying and performing a veterinary 
evaluation (Murphy 2009, Murphy 2011).   These practices have been utilized for both 
large and small animal incidents for a vast range of chemical, biological, and radioactive 
exposures (Houston and Hendrickson 2005, Kumar et al. 2010).   
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Canine decontamination procedures use both gross decontamination and 
technical decontamination techniques.  Gross decontamination removes the majority of 
surface contamination by using large amounts of water to rinse off loose particles from 
the animal’s coat (Murphy 2009).  Technical decontamination is a multi-step process 
that encompasses a detailed removal of the hazardous material from all external aspects 
of the animal’s body.  Methods utilized include brushing, vacuuming, and washing, to 
eliminate the contaminant from the animal (Houston and Hendrickson 2005, Murphy 
2009, Murphy 2011, Soric, Belanger and Wittnich 2008).  In short, technical 
decontamination is an extensive process and may require repeating steps to ensure the 
complete removal of the hazardous materials or toxic agents.  Historically, liquid dish 
soap has been the agent of choice for external technical decontamination (Murphy 2011).  
The physical properties found in liquid dish soap allow for binding and emulsification of 
particles: however, liquid dish soap has been known to contain surfactants which can 
introduce epidermal irritation following consecutive uses (Heyer 2011). Other agents 
such as hypochlorite solutions and chlorhexidine solutions have been utilized for 
biological decontamination, but have the drawback of time dependency.  Hypochlorite 
solution typically requires fifteen minutes and chlorhexidine requires six minutes of 
contact time with the skin to effectively denature biological agents (Heyer 2011).  This 
in itself may result in a skin irritation effect if used consecutively over a period of time.  
Canine Decontamination Challenges 
 The challenges associated with canine decontamination directly influence the 
effectiveness and efficiency of decontamination.   The efficiency of canine 
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decontamination varies and is dependent on factors such as anatomical site of 
contamination, chemical property and amount of the contaminant, and the timing and 
duration of decontamination (Chan et al. 2013). 
With currently utilized decontamination protocols, there is lack of containment to 
ensure safety for both the animal and individual decontaminating the animals.  Based on 
anecdotal evidence, small animal decontamination systems utilize small containment 
pools to progressively wash and move the animal through the decontamination process.  
This concept captures the contaminants and waste water, but consequently introduces 
secondary exposures to animals that are to follow through the decontamination process.    
As a result, commercial canine decontamination units were developed that allow animals 
to be washed on a raised platform thereby preventing animal contact with waste water 
(Figure 1).  In addition an elevated platform also allows for an increase in human 
efficiency by allowing decontamination personnel to work at a comfortable level.   
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Figure 1: Rapid Pro K9Decontamination Station
 
(Versar Industries) 
 
 
 
While the commercial canine decontamination units provide increased efficacy and 
waste water management, the systems do not increase the safety factor for the animal or 
decontamination personnel.  Contaminated animals are often disoriented or frightened, 
and for this reason, responder safety is equally as important as animal safety during the 
decontamination process.  
 External decontamination is considered a valuable tool in the removal of 
contaminants and in prevention of secondary exposures. However, decontamination has 
the potential to cause secondary health complications that are not related to the initial 
contamination issue.  From a dermatological standpoint, decontamination performed 
consecutively can result in an increased occurrence of epidermal complications.  
Anecdotal reports following the 2014 Washington State mudslide acknowledged that the 
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use of dish soap to remove mud and contaminants from S&R canines resulted in 
increased epidermal irritation (Gordon 2014).  Epidermal irritation developed after three 
consecutive days of performing decontamination with liquid dish soap.  Based on this 
observation, it has been hypothesized that the frequent use of dish soap may be a 
contributing or causal factor that resulted in compromised skin.  It is known that dish 
soap, and many other skin cleansing products, contain surfactants that allow for a 
reduction in surface tension between two liquids or between a liquid and a solid (Liem, 
Nater and Groot 1983).  Although these factors allow unwanted materials to be removed 
from the skin, subsequent epidermal irritation has been identified with the use of 
surfactant-based products (Table 2). 
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Table 2: Types of Surfactants 
Type of 
Surfactants 
Frequently Utilized 
Compounds 
Use Irritation 
Potential 
Anionic Sodium Laury Sulfate, 
Sodium Laureth Surfate, 
TEA-Lauryl Sulfatre 
Emulsifying, 
solubilizing, 
wetting agent, 
detergent 
High potent 
irritants to 
human and 
animal skin 
Cationic Quaternium-15, 
Quaternium-19, 
Stearalkoniumchloride 
Hair conditioning, 
antimicrobial, 
preservatives 
High potent 
irritants to 
human and 
animal skin 
Amphoteric Cocoamidopropyl 
Betaine, Coco-betaine, 
Disod, 
Cocoamphodiacetate 
Foam boosters, 
emulsifying, 
detergent 
Less irritation 
potential for eyes 
and skins 
Non-ionic Polysorbate 20, 
Cocamide DEA, 
Lauramide DEA 
Emulsifying, 
solubilizing, 
suspending agent, 
foam boosters, 
detergent  
Lowest irritant 
potential  
(Liem, Nater and Groot 1983) 
 
 
 
A soap’s surfactant properties are an important attribute with regards to 
decontamination but with repeated use have been found to cause damage to skin proteins 
and lipids, dryness, barrier damage, erythema, and irritation (Ananthapadmanabhan et al. 
2004).   Thus, repeated decontamination has the potential to decrease the inherent 
protection provided by healthy skin, and may increase the potential for the absorption of 
hazardous materials across the epidermis and into deeper skin layers, thereby increasing 
potential exposure to the rest of the body through the dermal blood supply.  These risks 
have not been tested nor modeled to determine the effects of daily decontamination 
during long-term deployments. 
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In an effort to identify potential irritation, two dermatological modalities have 
been identified in multiple studies as a way to track and quantify epidermal irritation.  
The Canine Atopic Dermatitis Extent and Severity Index (CADESI) is a qualitative 
approach that applies a visual scoring system to evaluate the extent and severity of 
lesions seen in canine atopic dermatitis (allergic skin disease) (Olivry et al. 2007).  This 
validated scoring system is utilized primarily for clinical trials in allergic canine patients. 
The system is designed to evaluate 62 body areas for signs of erythema, lichenification, 
excoriation, and self-induced alopecia.  A severity-based scoring system (0-5) is used to 
grade each location for the above criteria.  Following the completion of the visual 
scoring at each of the 62 body areas, a collective score is calculated.  The CADESI 
scoring system allows veterinarians (primarily veterinary dermatologists and 
researchers) to track severity of canine atopic dermatitis cases during anti-inflammatory 
therapy (Olivry et al. 2007).  In addition to the qualitative CADESI, quantitative 
assessments of epidermal irritation can be conducted by measuring Transepidermal 
Water Loss (TEWL).  The skin is a barrier that prevents the loss of water, but when 
damaged or compromised it results in an increased loss of water through the epidermis 
(Shimada et al. 2008).  TEWL measurements have been found to be an index that 
represents the barrier function of the epidermis.  To ensure proper measurements and 
exclude environmental factors, a closed chamber system is recommended for measuring 
TEWL.  Even with influential factors being limited, variability can be found from site-
to-site, day-to-day, and patient-to-patient with regards to TEWL measurements (Lau-
Gillard et al. 2010, Marsella 2012). 
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Conclusion 
 The potential release of harmful materials into the environment during an 
emergency or catastrophic event can contaminate the disaster site that S&R teams work 
in.  This release establishes an immediate health risk for S&R canines due to the lack of 
PPE.  Decontamination should provide an effective method for the mitigation of the 
exposure risk.  However, the outcomes of consecutive daily decontamination have not 
been evaluated to determine to what extent they produce dermatological adverse effects.  
Identifying the potential dermatological effects from sequential daily decontamination 
allows S&R teams a better understanding of how long S&R canines can be expected to 
work and receive daily decontamination without risk of secondary complications.  
Objectives and Aims 
 The objectives of this study were to determine the number of washes required for 
a high anionic versus a low anionic surfactant-based soap to remove oil-based 
contaminants and to compare the risks for development of transepidermal water loss and 
epidermal irritation from repeated decontamination.   
Hypothesis 
 Based on the literature reviewed, the following working hypotheses were 
proposed: 1) high anionic soap will require fewer washes to completely remove oil-
based contaminants from an animal’s coat than a low anionic soap; 2) transepidermal 
water loss will increase prior to visible epidermal irritation; 3) repeated decontamination 
with a high anionic soap will result in an increase of visible epidermal irritation as 
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compared to decontamination with a low anionic soap when compared for fourteen 
consecutive days.   
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MATERIALS AND METHODS 
 
Sample Size 
A Bayesian statistical model was developed to analyze the daily risk for 
epidermal irritation resulting from high and low anionic soap exposure.  Simulated 
datasets with sample sizes 10, 14, and 20 were generated, and each represented both 
extreme and slight differences in irritation resulting from the two treatments.  Bayesian 
analysis of the simulated datasets was performed and the computed results compared to 
the expected results Table 3.   
 
 
 
Table 3: Results of Simulated Datasets 
 Treatment A at day 11 Treatment B at day 12 
N, Sample Median CI Median CI 
10 3.68 [1.9, 8.0] 2.138 [0.3, 6.1] 
14 4.184 [2.3, 8.5] 2.487 [0.3, 10.3] 
20 4.165 [2.5, 7.4] 3.318 [1.3, 9.2] 
 
 
 
Analysis of simulated databases at a sample size of 10 validated the Bayesian 
model’s ability to detect slight and extreme differences in epidermal irritation with a 
95% confidence and minimal sample size. An increased sample size of fourteen or 
twenty did not provide a significant advantage in the detection of both extreme and 
slight differences in epidermal irritation associated with each treatment.  
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Animals 
 Ten Coonhounds were obtained from a commercial breeder.  The animals used in 
this study were approved by the Texas A&M Institutional Animal Care and Use 
Committee (IACUC) under AUP # 2013-0185.  Inclusion criteria for the study were: 
healthy Coonhounds 2 years of age of similar in weight (45-75 lbs.) and receiving the 
same diet.  Physical examinations were conducted upon arrival to determine each 
animal’s suitability for inclusion in the study.   In addition, a dermatological evaluation 
was performed by a veterinary dermatologist to identify dogs with current 
dermatological complications.  Seven dogs were classified as short coarse hair coat, 2 
dogs as short fine hair coats, and 1 dog as normal hair coat.  Dogs were individually 
housed during the study period in a climate controlled building with environmental 
conditions maintained at a temperature of 22 °Celsius and 58 % humidity.   
Experimental Design 
 All dogs underwent three different trials over a nine-week study period.   
Trial 1 was a single day observational study that evaluated the efficacy of high and low 
anionic surfactant-based soaps in the removal of oil-based contaminants.  Ten dogs were 
randomly assigned to treatment groups A or B as shown in Table 4.  A non-toxic 
fluorescent impregnated oil-based liquid, GloGerm™1, was utilized to replicate an oil-
based contaminant.  Visual detection of GloGerm™ required the use of ultraviolet light 
in a dark room.  Sixty mls of GloGerm™ was applied externally to each canine’s coat 
                                                 
1 GloGerm was purchased from GLOGERM.  The product was composed of USP white miner oil and   
 Synthetic Organic Colorant 
 17 
 
and allowed to dry for 10 minutes.   Following the application and drying of 
GloGerm™, dogs were bathed with Dawn Ultra®2 or DermaLyte®3 and rinsed 
thoroughly.   
 
 
 
Table 4: Trial 1 Study Design 
 Group A Group B 
Dog Exposure Treatment *Washes Dog Exposure Treatment *Washes 
1 GloGerm Dawn®   6 GloGerm DermaLyte®  
2 GloGerm Dawn®   7 GloGerm DermaLyte®  
3 GloGerm Dawn®   8 GloGerm DermaLyte®  
4 GloGerm Dawn®   9 GloGerm DermaLyte®  
5 GloGerm Dawn®   10 GloGerm DermaLyte®  
* Washes: represent the total number of washes required for each treatment to remove GloGerm™ 
 
 
 
At the completion of each wash, dogs were evaluated under an ultraviolet light to 
detect the presence of GloGerm™.  If fluorescent material was detected on the canine’s 
coat or skin, additional washing was performed.  The washing and rinsing process was 
repeated until all fluorescent material was completely removed externally from the 
dog.  The total number of washes required to remove the fluorescent material was 
recorded for each dog.  The median quantity amount of washes determined in Trial 1 for 
                                                 
2 Dawn Ultra is manufactured by Procter & Gamble Co. and classified as a high anionic surfactant-based 
product 
3 Dermalyte is manufactured by Dechra Veterinary Products and classified as a low anionic surfactant-
based product 
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both treatments was utilized as the standard for the number of washes for both treatment 
groups in Trial 2 and 3.  
Trial 2 and 3 utilized a crossover study design that modeled and evaluated 
epidermal irritation and transepidermal water loss (TEWL) resulting from consecutive 
daily bathing with a high anionic or low anionic soap.  The crossover allowed for each 
study participant to be exposed and evaluated for each treatment.  For Trial 2, 10 dogs 
were randomly assigned to treatment groups and washed daily for 14 consecutive days.  
Dogs in treatment Group A were washed twice with DermaLyte® dog shampoo, while 
the dogs in treatment Group B were washed once with Dawn®  Ultra® Table 5.  Each 
day, prior to washing all dogs received full body dermatological evaluations by a 
veterinary dermatologist and Transepidermal Water Loss (TEWL) measurements were 
taken at 19 locations.  The 19 generalized locations are based on a modified version of 
the CADESI scoring system.  All visual epidermal evaluations were assessed by a 
veterinary dermatologist daily to ensure the proper identification of irritation resulting 
from both treatments.   
 
 
 
Table 5: Trial 2 Study Design 
Group A Group B 
Dog Tx *Wash Derm TEWL Dog Tx *Wash Derm TEWL 
1 DermaLyte® 2   6 Dawn®  1   
2 DermaLyte® 2   7 Dawn®  1   
3 DermaLyte® 2   8 Dawn®  1   
4 DermaLyte® 2   9 Dawn®  1   
5 DermaLyte® 2   10 Dawn®  1   
*Wash- Median number of washes required to remove GloGerm™ externally from an animal’s coat for 
each treatment.  Data was derived from Trial 1. 
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Trial 3 replicated the procedures in Trial 2 with the exception that the dogs in 
treatment Group A were washed once with Dawn®  Ultra®, and dogs in treatment 
Group B will be washed twice with DermaLyte® dog shampoo as seen in Table 6. 
 
 
 
Table 6: Trial 3 Study Design 
Group A Group B 
Dog Tx *Wash Derm TEWL Dog Tx *Wash Derm TEWL 
1 Dawn®  1   6 DermaLyte® 2   
2 Dawn®  1   7 DermaLyte® 2   
3 Dawn®  1   8 DermaLyte® 2   
4 Dawn®  1   9 DermaLyte® 2   
5 Dawn®  1   10 DermaLyte® 2   
*Wash- Median number of washes required to remove GloGerm externally from an animal’s coat for each 
treatment.  Data was derived from Trial 1. 
 
 
 
Washout Period 
Upon completion of Trial 1, there was a seven-day recovery period to allow dogs 
to fully recover from any epidermal complications resulting from Trial 1. Dogs were 
monitored daily to record progress of recovery and evaluated by a veterinary 
dermatologist prior to initiating additional trials. The completion of Trial 2 called for a 
30 day recovery period to ensure all previous dermatological complications from the 
proceeding trial had resolved and to prevent carryover bias between Trials 2 and 3. 
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Canine Decontamination Protocol 
 For this study a standardized 10 minute washing procedure was utilized for all 
trials.  All washing took place in a companion animal decontamination unit designed to 
provide containment for the animal and waste material during the washing process.  
Dogs were first rinsed with water for one minute, followed by a scrubbing period of five 
minutes with one of the treatment soaps.  An application of 120mls of soap per wash was 
spread evenly over the animal’s body and worked into the coat.  Dogs were then rinsed 
from head to tail and dorsum to ventrum for four minutes.  Following the completion of 
washing, each dog was removed from the decontamination unit, toweled dry, and 
returned to the pen.  
Canine Decontamination Unit 
 A mobile companion animal decontamination unit was designed and built by the 
Texas A&M Veterinary Emergency Team to facilitate the washing for this project 
(Figure 2).  The steel/plexiglass structure allowed animals to be fully contained within a 
closed chamber system while being washed (Figure 2).  After reviewing anecdotal 
evidence, the development of an enclosed system was favored as a means to provide 
safety and mitigate exposure to contaminants for both the animal and the 
decontamination personnel.  The unit provided a physical barrier of protection between 
the animal and personnel performing the wash.  The individual performing washing 
would reach though the access holes and wear arm length rubber gloves to scrub and 
rinse the animal.  In addition, all wastewater and materials were captured within a 
recessed reservoir that prevented the animal from standing in potentially contaminated 
 21 
 
water. Entrance and exit ramps were installed to ensure safety and ease of moving 
animals in and out of the unit.  
 
 
 
Figure 2: Companion Animal Decontamination Unit  
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Epidermal Evaluations 
Epidermal irritation was visually scored on a condensed modified version of the 
Canine Atopic Dermatitis Extent and Severity Index (CADESI), (Appendix A).  The 
CADESI evaluates and scores 62 locations on the dog’s skin for signs of erythema, 
lichenification, excoriation, and self-induced alopecia.   The 62 locations were grouped 
and generalized into 19 locations, in order to simplify the evaluation system and provide 
the ability to classify the occurrence of epidermal irritation into broad body regions.  The 
modified version of the CADESI evaluated the 19 generalized locations for visual signs 
of erythema, excoriation, and self-induced alopecia.  The modified CADESI utilized a 
scale of zero to five (0: None, 1: Mild, 2-3: Moderate, 4-5: Severe) to score each 
location.  Guidelines for scoring erythema, excoriation, and self-induced alopecia were 
developed to ensure consistency of scoring during the study (Appendix B).   All skin 
evaluations were performed by a veterinary dermatologist to ensure accurate and 
consistent scoring according to dermatology standards.  During the course of the study, 
the dermatologist remained blinded to both treatment groups.   
Participant Withdrawal  
Any dog with a score of 2 or greater for erythema or excoriation based on the 
CADESI scoring system resulted in the dog being removed from the study and from 
further treatments (washing) for the remainder of the trial.  This protocol was in place to 
ensure that animals were not washed to the point that dermatological irritation was 
inhumane or resulted in potential health complications.  Animals that were withdrawn 
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from the trial still received daily epidermal evaluations and TEWL measurements to 
monitor the progression/resolution of epidermal irritation and recovery.  
Transepidermal Water Loss 
Transepidermal water loss measurements were taken at the nineteen locations 
evaluated by the modified-CADESI.  A closed-chamber VapoMeter®4 was utilized to 
collect measurements on the nineteen locations.  The probe required 10-second contact 
time to acquire a measurement at each location. All data were transferred wirelessly to 
the Delfin management software on a laptop computer.  
Statistical Analysis 
Descriptive statics were used to quantify and summarize data collected from 
Trial 1.  Ninety-five percent confidence intervals were calculated for the median number 
of washes for Dawn® and DermaLyte® to remove GloGerm™.  In addition descriptive 
statics were utilized to summarize hair coat classification, summary of visual 
dermatological effects, and patient withdrawal.  
Bayesian statistical methods were employed to analyze the visual dermatological 
evaluations and the TEWL data collected in Trials 2 and 3.  Two independent models 
were composed and the parameters were estimated using a Markov Chain Monte Carlo 
(MCMC) method using OpenBugs version 3.2.3 software (Lunn et al. 2009).  
A time-to-event model was developed to generate median survival times at a 
95% confidence interval to test the hypothesis that repeated decontamination with a high 
                                                 
4VapoMeter manufactured by Delfin technologies 
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anionic soap will result in an increase of visible epidermal irritation as compared to 
decontamination with a low anionic soap over fourteen consecutive days (Congdon 
2007).  Time-to-event analysis accounts for both the period of observation and whether 
an event occurred or not. The approach for this study was to model the events 
excoriation, erythema, and self-induced alopecia that were the basis of the modified 
CADESI scoring system.  Scoring for erythema and excoriation were summarized into a 
single score that represented the highest identified dermatological complication for any 
given location.  The likelihood survival time for each level of epidermal severity was 
modeled as a Weibull distribution.  The logit of the Weibull parameter was modeled as a 
linear function of an intercept, a random effect for dog, treatment effect, and the effect of 
treatment order.  Vague priors were used for the model coefficients (Congdon 2007). 
Two separate Bayesian statistical models were utilized to model the 
measurements of TEWL.  The first model used a Poisson distribution to evaluate the 
change in TEWL over the 14 day treatment period. were modeled The log of the Poisson 
parameter was then modeled as a linear combination of: a treatment-specific intercept, 
random effects for both dog and location and the effect of treatment as a day-specific 
effect (Congdon 2007). To evaluate any potential effect of treatment order, in the cross-
over design, the effect of treatment order was included in the original model and when it 
was confirmed that there was no effect of order, the modeling was completed without a 
treatment order parameter. A Bayesian implementation with vague or minimally 
informative priors was used for analysis. Specifically, the priors where uniform (-
infinity, +infinity) for the treatment specific intercepts (Congdon 2007).  Both dog and 
 25 
 
location were assigned vague normal random priors that included a mean of zero and 
gamma precision parameter of (0.01, 0.01).  For the effect of (treatment and day) 
specific to time, a random-walk prior was used (Lunn et al. 2009).  The effect of each 
treatment was assigned a normal prior with zero mean and a precision of 0.001 
The second model evaluated the possibility that treatment effects were different 
among locations. Model 1 was adapted by removing the random effect for location and 
then providing separate random walk priors for treatment and day combinations, 
allowing autoregressive smoothing across days. Models 1 and 2 were compared by 
evaluating the posterior for the temporally smoothed treatment effects among locations 
and by evaluating the Deviance Information Criterion for the two models.  
The implementation was performed within OpenBugs version 3.2.3 (Lunn et al. 
2009).  A burn-in of 5,000 iterations and a sampling of 100,000 iterations were used for 
the MCMC simulation.  The Bayesian estimate was taken as the posterior median of the 
parameter.  The confidence interval at 2.5% and 97.5% percentiles were taken directly 
from the posterior distribution.  Statistical significance was defined as 95% confidence 
interval for the survival times and changes in TEWL that excluded <1. 
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RESULTS 
 
Effectiveness of a High and Low Anionic Soap 
 The median number of washes and amount of soap to effectively remove oil 
based contaminants was determined for each treatment (Table 7 and 8 respectively). 
Tabulated data is provided in Appendix C. 
 
 
Table 7: Median Number of Washes 
Treatment N Mean STDEV Median Min Max 
Dawn®  5 1.4 0.89 1 1 4 
DermaLyte® 5 2.4 0.55 2 2 3 
 
 
 
Table 8: Median ml of Soap 
Treatment N Mean STDEV Median Min Max 
Dawn®  5 168ml 107.33 120ml 120ml 360ml 
DermaLyte® 5 288ml 65.73 240ml 240ml 360ml 
 
 
 
Epidermal Irritation 
 One hundred percent of dogs exposed to Dawn® and 90% of dogs exposed to 
DermaLyte® developed clinical signs of epidermal irritation during the study period. 
The individual daily dermatological summary score (maximum combined severity score 
for erythema, excoriation, and self-induced alopecia) for each treatment group and 
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tabulated data is provided in Appendix D. Figures 3 and 4 display the frequency of dogs 
that reached each severity level of excoriation based on location while Figures 5 and 6 
express the frequency of dogs that reached each severity level of erythema based on 
location. Two dogs exposed to DermaLyte® showed signs of alopecia at the sternum 
region.  Alopecia was not identified on any of the 10 dogs exposed to Dawn®. The 
patient withdrawal rate is provided in Figure 7. 
 
 
Figure 3:Erythema Occurrences by Location with DermaLyte® Exposure 
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Figure 4: Erythema Occurrences by Location with Dawn® Exposure
 
 
 
 
Figure 5: Excoriation Occurrences by Location with DermaLyte® Exposure 
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Figure 6: Excoriation Occurrences by Location with Dawn® Exposure 
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Figure 7: Participant Withdrawal From Study as a Result of Moderate Epidermal 
Irritation 
 
*Patients receiving a score of 2 or greater for erythema or excoriation based on the CADESI scoring 
system resulted in the animal being removed from the study.  
 
 
 
Time to Event for Visual Dermatological Effect Indices 
 The median and 95% Confidence Intervals (CI) for the expected median survival 
time for each of the severity indices compiled from the modified CADESI is provided in 
Table 9.  Severity index 4 for Dawn® treatment and severity index 5, for both 
DermaLyte® and Dawn® treatments, were not computed as a result of the absence of 
data for these indices.   
 
 
Table 9: Expected Median Time (days) for Severity Occurrence 
Severity Levels DermaLyte® Median (95%CI) Dawn®  Median (95% CI) 
1 (Mild) 7.7 (5.6-10.6) 6.6  (5.0-8.9) 
2 (Moderate) 13.9 (10.1-21.4) 10.9 (7.9-15.8) 
3 (Moderate) 24.3 (15.5-45.7) 25.6 (15.2-54.3) 
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Transepidermal Water Loss 
Table 10 represents the median relative daily risk for TEWL over the 14 
collection times for both treatment groups.  Table 11 shows the median TEWL daily 
relative risk for the difference between treatment groups over the collection period.  
Table 12 represents the expected differences between 2 consecutive days within a 
treatment group, the expected difference between 2 dogs, and the expected difference 
between 2 collection locations on a single dog.  Calculated location specific median 
relative risks for each treatment group are provided in Appendix E. 
 
 
Table 10: Median Relative Daily Risk for TEWL 
 DermaLyte® Dawn®  
Day Mean Median 95% CI Mean Median 95% CI 
1 1.094 1.094 1.049-1.141 1.013 1.013 0.9705-1.057 
2 0.9482 0.9481 0.9064-0.9904 0.9271 0.9269 0.8869-0.9679 
3 1.053 1.053 1.009-1.098 1.011 1.011 0.9702-1.054 
4 1.085 1.084 1.04-1.13 1.099 1.098 1.055-1.144 
5 1.057 1.057 1.014-1.102 1.065 1.065 1.023-1.109 
6 1.05 1.049 1.006-1.094 1.032 1.032 0.99-1.074 
7 1.143 1.142 1.096-1.19 0.9739 0.9738 0.9332-1.015 
8 0.9991 0.9989 0.9564-1.042 0.9599 0.9598 0.92-1 
9 0.9983 0.9981 0.9561-1.041 0.969 0.9689 0.9291-1.01 
10 0.8579 0.8578 0.8184-0.8977 0.9714 0.9712 0.9306-1.013 
11 0.9038 0.9037 0.8644-0.9444 1.087 1.087 1.043-1.134 
12 0.8894 0.8893 0.85-0.93 0.9424 0.9422 0.9019-0.9833 
13 0.8974 0.8972 0.8573-0.938 0.9635 0.9634 0.9234-1.005 
14 1.082 1.082 1.037-1.129 1.007 1.007 0.9645-1.05 
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Table 11: Median TEWL Relative Risk Between Treatment Groups 
Day Median 95% CI 
1 1.08 1.017-1.146 
2 1.023 0.961-1.088 
3 1.041 0.9815-1.104 
4 0.9874 0.9321-1.046 
5 0.9925 0.9368-1.051 
6 1.017 0.9595-1.078 
7 1.173 1.107-1.244 
8 1.041 0.98-1.105 
9 1.03 0.970-1.094 
10 0.8833 0.8297-0.9398 
11 0.8314 0.7821-0.8834 
12 0.9437 0.8869-1.005 
13 0.9314 0.8756-0.9904 
14 1.075 1.012-1.141 
 
 
 
Table 12: Standard Deviation of Collection Days, Dog, & Collection Location 
 Mean Median 95% CI 
Day: DermaLyt 0.11 0.11 0.07-0.18 
Day: Dawn®  0.09 0.09 0.06-0.14 
Dog 0.18 0.17 0.11-0.34 
Collection Location 0.24 0.23 0.17-0.34 
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DISCUSSION 
 
While contamination of canines working in hazardous environments is a concern, 
the decontamination process used to remove these contaminants has the potential to 
cause secondary health complications.  The effectiveness of decontaminating dogs 
exposed to oil-based substances has not been assessed, nor have the dermatological 
effects associated with repeated daily decontamination.  The results of this study showed 
that Dawn® required a single wash to remove an oil-based contaminant vs two washes 
with DermaLyte® to achieve the same effect.  The increased efficiency of Dawn® will 
allow for a reduction in the time required to decontaminate an animal and potentially 
conserve resources such as water, soap, and labor force.  
Although Dawn® was found to be more effective than DermaLyte® at removing 
oil-based substances; both soaps induce dermatological complications with sequential 
daily use.  The initiation of epidermal irritation as measured by visual dermatological 
assessment and scoring was found to be associated with repeated treatments of both 
Dawn® (high anionic surfactant) and DermaLyte® (low anionic surfactant) soaps over 
14 consecutive days.  The time-to-event analysis revealed there was no significant 
difference, based on a 95% CI, in time to occurrence for each of the severity indices 
between treatment groups.  Regardless, it is importance to acknowledge the time periods 
for which each severity indices is expected to occur as a result of continuous treatment.  
Dawn® resulted in mild irritation between days 4.9 and 8.8, and between days 7.8 to 
15.8 for moderate irritation.  Daily use of DermaLyte® resulted in mild irritation 
 34 
 
between days 5.8 and 10.6 and moderate irritation between days 10.1 and 21.4.  With 
daily use of Dawn®, dogs developed moderate irritation at a faster rate than dogs 
exposed to DermaLyte®.   
A summary of the modified CADESI revealed areas of location-dependent risk 
for development of erythema, excoriation, and self-induced alopecia.  Areas of increased 
location-dependent risk accounted for 5 or more dogs that presented in each of the 
severity indices. The lumbar, dorsal thorax, right and left lateral thorax, and sternum 
regions were all locations that represented an increased risk of mild erythema that were 
consistent between the two treatment groups.  However, exposure to Dawn® did result 
in two additional regions (abdomen and right inguinal) for high risk of mild erythema.  
The dorsal thorax was the only location that resulted in a high risk for moderate 
erythema and was consistent between the two treatment groups.  No locations were 
found to be of high risk for severe erythema between both treatment groups.  Location-
dependent regions for the presence of excoriation included: head, neck, sternum, right 
lateral thorax, dorsal thorax, abdomen, and lumbar regions.  These regions represented 
areas were excoriation was detected; however these regions were not classified as high 
risk.  When comparing the location specific erythema and excoriation incidences, 
erythema occurrences were significantly higher than excoriation occurrences.  Two 
occurrences of self-induced alopecia were identified in the DermaLyte® treatment group 
on the sternum region, but the data did not support an association between hair loss and 
treatment.  Based on these findings, erythema is the most commonly noted 
dermatological complication appreciated in canines as a result of serial decontamination. 
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In this study, the assessment of TEWL revealed there was an increased risk for 
TEWL on days 1, 3, 4, 5, 6, 7, and 14 as a result of exposure to DermaLyte®, and days 
4, 5, and 11 as a result of exposure to Dawn®.   However these increased risks in TEWL 
cannot be credited exclusively to individual treatments.  An increased variability was 
identified between dogs and measurement locations consecutively over the 14 day 
treatment period.  Also the expected differences in TEWL between consecutive days 
were similar between the two treatment groups.  Based on this study TEWL cannot 
provide an accurate early detection for the onset occurrence of visual epidermal 
irritation.  
The companion animal decontamination unit was used a total of 215 times 
throughout the study.  All animals were properly contained in the unit during the 
washing period.  The enclosed unit provided a safety barrier that ensured the animal 
could not exit the unit during the washing process.  The ramps allowed the patients to 
easily be loaded and removed from the unit.   In addition, a minimal amount of water 
and soap escaped the unit around the arm holes where the individuals performing the 
washing reached through. 
Study Limitations  
Skin and hair quality variability can be found among animal species, breeds, and 
individuals within a breed.  In this study, 7 dogs were classified as short coarse hair coat, 
2 dogs as short fine hair coats, and 1 dog as normal hair coat. The dog that classified 
with a normal hair coat was the only dog that did not develop visual signs of moderate 
epidermal irritation for both Dawn® and DermaLyte® treatments. As a result skin and 
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hair quality should be included in the inclusion criteria, to ensure a uniform sample 
population.  Furthermore, there is individual variability due to age, gender, and between 
evaluation locations.  Areas that contain the thickest skin are found on the forehead, 
dorsal neck, dorsal thorax, rump, and base of the tail, while the pinnal, axillary, inguinal, 
and perianal areas possess the thinnest skin.  Areas with thin skin have a higher potential 
of absorption and permeability of substances due to the decreased number of skin cells 
present within the epidermal layer.  Therefore thickness of skin is a potential 
confounding factor that prevents uniformity throughout the animal’s body.  This means 
that not all areas of a given canine have the same risk for the development of epidermal 
irritation and potential absorption of hazardous materials.   
The CADESI uses a total of 62 locations to adequately score and assess a 
canine’s entire body.  In this study, we created a modified version of the CADESI by 
grouping the 62 regions into 19 individual locations.   The19 locations identified for the 
visual detection were also employed for the TEWL measurement sites.  By generalizing 
the visual scoring and TEWL measurements locations, we limited our ability to 
accurately assess TEWL based on location specific areas.  The CADESI organizes the 
visual assessment areas of a canine’s forelimb into 4 different areas (the medial, lateral, 
cubital flexor and carpal flexor) and the modified CADESI we used for this study 
grouped these 4 areas into one single location/measurement site.  This means that during 
our visual assessment of a canine’s forelimb we looked at medial, lateral, cubital flexor 
and carpal flexor as one whole area, but when we measured TEWL the probe was placed 
in the general vicinity of the forelimb.  A Vapometer is designed to measure a 1cm 
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diameter area per measurement.  Due to the small area captured by the Vapometer there 
is an increased variability between collection locations within a generalized area. By 
generalizing all these regions to represent a single location, the TEWL measurement 
could potentially not get collected in the same region as the presence of the epidermal 
irritation.  One way to reduce the location TEWL variability is to apply the original 62 
locations specified in the CADESI.  Using 62 locations rather than 19, would allow for 
TEWL measurement to be taken within the actual area and not a large generalized 
region.  In addition, triplicate TEWL measurements within the 62 locations would allow 
for an improved sampling of TEWL for a given location rather than basing the findings 
on a single measurement.  
The participant withdrawal was an important aspect to insure that inhumane 
health complications did not arise from prolonged exposure to either treatment 
throughout the study period.   Moderate (severity index 2) at any location was defined as 
the treatment withdrawal point for the remainder of the trial.  Consequently by removing 
dogs at a moderate severity level 2, we were unable to detect a significant amount of 
data that support moderate (severity 3) and severe (severity 4 & 5) dermatological 
complications based on treatment exposure. Although treatment ceased, visual 
evaluations and TEWL measurements were still taken following a patient’s withdrawal 
from the trial.  Continuing TEWL measurements after a patient was removed from the 
trial introduced fallout bias.  Our statistical model for TEWL did not take into account 
when an animal was removed from the trial.  This introduced a mixing of data between 
animals on the trial and animals removed from the trial and reduced the accuracy of 
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assessing the change in TEWL based on treatment.  In addition, two animals developed 
lacerations and abrasions on neck, thorax dorsal, and forelimb regions as a result of 
injuries obtained during the treatment period.  These injuries were not directly related to 
the treatment and resulted in the moderate and severe epidermal irritation at the 
respective locations.  Fortunately, prior to receiving these injuries, the two animals were 
removed from the treatment groups as a result of the detection of moderate epidermal 
irritation.  
From a statistical analysis perspective, a Bayesian Model was developed to 
assess the daily changes in visual epidermal complications and was validated using 
random generated data sets.  The initial model and data sets determined the sample size 
for the study.  After completing the study, we found that the initial model did not 
account for time-to-event analysis.  As a result, we generated a new model to assess the 
visual epidermal irritation as a time-to-event.  The new model potentially could have 
required a different sample size to conclude significance.  
 A final limitation to the study was standardizing the washing protocol for time 
and amount of soap utilized per wash.  In setting the wash standard, we did not account 
for animal surface area and number of gallons of water needed or used to wash each dog. 
Calculating the appropriate dosage of each soap for the animal’s surface area would 
potentially prevent the over exposure of soap to the animal, which could reduce the 
occurrences of epidermal irritation.  This data would have provided significant insight 
into the logistical requirements for decontaminating canines that range in size for future 
deployments.   
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While we acknowledge these potential limitations, we still feel that this study 
provided a significant step forward in understanding the potential effects that could be 
introduced through sequential daily decontamination and for future research projects.  
 
 
 
 
 40 
 
SUMMARY AND CONCLUSIONS 
 
 There are several relevant conclusions that can be drawn from the study.  First, 
this study showed that Dawn®, a high anionic soap, has a higher degree of effectiveness 
when compared to DermaLyte®, a low anionic soap, to externally decontaminate 
canines with an oil-based contaminant exposure.  Second, this study showed that search 
and rescue canines will not be able to work and receive daily sequentially 
decontamination for 14 days, regardless of being decontaminated strictly with Dawn® or 
DermaLyte®.   Nonetheless, this study still provided ranges for guidance on potential 
epidermal irritation that could arise from consecutive daily decontamination:  daily 
exposure to Dawn® will result in mild to moderate epidermal irritation between days 4.9 
and 15.76, while DermaLyte® will produce the same results between days 5.8 and 21.4.  
Finally, this study showed that TEWL measurement cannot be used as an early detection 
of potential epidermal irritation.  Visual epidermal evaluation remains the more accurate 
method for determining when secondary irritation from consecutive decontamination 
presents. 
 
 
 
 
 
 
 41 
 
REFERENCES 
 
Ananthapadmanabhan, K. P., D. J. Moore, K. Subramanyan, M. Misra and F. Meyer. 
2004. "Cleansing without Compromise: The Impact of Cleansers on the Skin 
Barrier and the Technology of Mild Cleansing." Dermatol Ther 17 Suppl 1:16-
25. 
 
Banauch, G. I., A. Dhala and D. J. Prezant. 2005. "Pulmonary Disease in Rescue 
Workers at the World Trade Center Site." Curr Opin Pulm Med 11(2):160-8. 
 
Chan, H. P., H. Zhai, X. Hui and H. I. Maibach. 2013. "Skin Decontamination: 
Principles and Perspectives." Toxicol Ind Health 29(10):955-68. doi: 
10.1177/0748233712448112. 
 
Congdon, P. 2007. Bayesian Statistical Modelling: Wiley. 
 
Gordon, L. E. 2012. "Injuries and Illnesses among Urban Search-and-Rescue Dogs 
Deployed to Haiti Following the January 12, 2010, Earthquake." J Am Vet Med 
Assoc 240(4):396-403. doi: 10.2460/javma.240.4.396. 
 
Gordon, Lori. 2014. "Sr-530 Slide Oso, Washing Canine Illness and Injury Report." 
 
Gwaltney-Brant, S. M., L. A. Murphy, T. A. Wismer and J. C. Albretsen. 2003. "General 
Toxicologic Hazards and Risks for Search-and-Rescue Dogs Responding to 
Urban Disasters." J Am Vet Med Assoc 222(3):292-5. 
 
Heyer, Robert. 2011. "Emergency Biological Decontamination Solutions." 
 
Houston, M. and R. G. Hendrickson. 2005. "Decontamination." Crit Care Clin 
21(4):653-72, v. doi: 10.1016/j.ccc.2005.06.001. 
 
Jones, K. E., K. Dashfield, A. B. Downend and C. M. Otto. 2004. "Search-and-Rescue 
Dogs: An Overview for Veterinarians." J Am Vet Med Assoc 225(6):854-60. 
 
Kumar, V., R. Goel, R. Chawla, M. Silambarasan and R. K. Sharma. 2010. "Chemical, 
Biological, Radiological, and Nuclear Decontamination: Recent Trends and 
Future Perspective." J Pharm Bioallied Sci 2(3):220-38. doi: 10.4103/0975-
7406.68505. 
 
Lau-Gillard, P. J., P. B. Hill, C. J. Chesney, C. Budleigh and A. Immonen. 2010. 
"Evaluation of a Hand-Held Evaporimeter (Vapometer) for the Measurement of 
 42 
 
Transepidermal Water Loss in Healthy Dogs." Vet Dermatol 21(2):136-45. doi: 
10.1111/j.1365-3164.2009.00738.x. 
 
Leary, A. D., M. D. Schwartz, M. A. Kirk, J. S. Ignacio, E. B. Wencil and S. M. 
Cibulsky. 2014. "Evidence-Based Patient Decontamination: An Integral 
Component of Mass Exposure Chemical Incident Planning and Response." 
Disaster Med Public Health Prep 8(3):260-6. doi: 10.1017/dmp.2014.41. 
 
Liem, Dhiam H., Johan P. Nater and Anton C. de Groot. 1983. Unwanted Effects of 
Cosmetics and Drugs Used in Dermatology. Amsterdam ; Princeton : New York, 
NY: Excerpta Medica ; Sole distributors for the U.S.A. and Canada, Elsevier 
Science Pub. Co. 
 
Lunn, D., D. Spiegelhalter, A. Thomas and N. Best. 2009. "The Bugs Project: Evolution, 
Critique and Future Directions." Stat Med 28(25):3049-67. doi: 
10.1002/sim.3680. 
 
Marsella, R. 2012. "Are Transepidermal Water Loss and Clinical Signs Correlated in 
Canine Atopic Dermatitis? A Compilation of Studies." Vet Dermatol 23(3):238-
e49. doi: 10.1111/j.1365-3164.2012.01055.x. 
 
Migala, A. F. and S. E. Brown. 2012. "Use of Human Remains Detection Dogs for Wide 
Area Search after Wildfire: A New Experience for Texastask Force 1 Search and 
Rescue Resources." Wilderness Environ Med 23(4):337-42. doi: 
10.1016/j.wem.2012.05.005. 
 
Murphy, L. A., S. M. Gwaltney-Brant, J. C. Albretsen and T. A. Wismer. 2003. 
"Toxicologic Agents of Concern for Search-and-Rescue Dogs Responding to 
Urban Disasters." J Am Vet Med Assoc 222(3):296-304. 
 
Murphy, Lisa. 2009. Basic Veterinary Decontamination: Who, What, Why?, Edited by 
W. Wingfield and S. Palmer: John Wiley & Sons. 
 
Murphy, Lisa. 2011. "Decontamination Procedures." Pp. 51-56 in Small Animal 
Toxicology Essentials: John Wiley & Sons, Inc. 
 
Olivry, T., R. Marsella, T. Iwasaki, R. Mueller and International Task Force On Canine 
Atopic Dermatitis. 2007. "Validation of Cadesi-03, a Severity Scale for Clinical 
Trials Enrolling Dogs with Atopic Dermatitis." Vet Dermatol 18(2):78-86. doi: 
10.1111/j.1365-3164.2007.00569.x. 
 
Pittman, William, Zhe Han, Brian Harding, Camilo Rosas, Jiaojun Jiang, Alba Pineda 
and M. Sam Mannan. 2014. "Lessons to Be Learned from an Analysis of 
 43 
 
Ammonium Nitrate Disasters in the Last 100 Years." Journal of Hazardous 
Materials 280(0):472-77. 
 
Reible, D., C. Haas, J. Pardue and W. Walsh. 2006. "Toxic and Contaminant Concerns 
Generated by Hurricane Katrina." Journal of Environmental Engineering 
132(6):565-66. doi: 10.1061/(ASCE)0733-9372(2006)132:6(565). 
 
Shimada, K., T. Yoshihara, M. Yamamoto, K. Konno, Y. Momoi, K. Nishifuji and T. 
Iwasaki. 2008. "Transepidermal Water Loss (Tewl) Reflects Skin Barrier 
Function of Dog." J Vet Med Sci 70(8):841-3. 
 
Soric, S., M. P. Belanger and C. Wittnich. 2008. "A Method for Decontamination of 
Animals Involved in Floodwater Disasters." J Am Vet Med Assoc 232(3):364-70. 
doi: 10.2460/javma.232.3.364. 
 
Versar Industries. "Rapid Pro K9 Decontamination Station." Enviromental Management 
System & Construction Porject Management Services.  
 
Wenzel, J. G. 2007. "Awareness-Level Information for Veterinarians on Control Zones, 
Personal Protective Equipment, and Decontamination." J Am Vet Med Assoc 
231(1):48-51. doi: 10.2460/javma.231.1.48. 
 
Young, S., L. Balluz and J. Malilay. 2004. "Natural and Technologic Hazardous 
Material Releases During and after Natural Disasters: A Review." Sci Total 
Environ 322(1-3):3-20. doi: 10.1016/S0048-9697(03)00446-7. 
 
  
 44 
 
APPENDIX A 
CANINE ATOPIC DERMATITIS EXTENT AND SEVERITY INDEX 
 
 
Figure A-1 
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APPENDIX B 
MODIFIED CANINE ATOPIC DERMATITIS EXTENT AND SEVERITY INDEX& 
VISUAL SCORING SYSTEM  
 
Figure B-1: Scoring Locations  
 Location 
 
Erythema (0-5) 
 
 
Excoriation (0-5) 
 
 
Alopecia (0-5) 
 
   1 Head       
2 Neck       
3 Right Front Limb       
4 Left Front Limb       
5 Right Axilla       
6 Left Axilla       
7 Sternum       
8 Thorax Right Lateral       
9 Thorax Left Lateral       
10 Dorsal Thorax        
11 Abdomen       
12 Lumbar       
13 Right Inguinal       
14 Left Inguinal       
15 Right Back Limb       
16 Left Back Limb       
17 Right Flank       
18 Left Flank       
19 Tail       
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     Figure B-2: Erythema Scoring 
Scoring Classification Visual 
0 None 
 
1 Mild 
 
2 Moderate 
 
3 Moderate 
 
4 Severe 
 
 
5 Severe 
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    Figure B-3: Excoriation Scoring 
Scoring Classification Visual 
0 None 
 
1 Mild 
 
2 Moderate 
 
3 Moderate 
 
4 Severe 
 
   
5 Severe 
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    Figure B-4: Alopecia (Self-Induced) Scoring 
Scoring Classification Visual 
0 None 
 
1 Mild 
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APPENDIX C 
 
EFFECTIVENESS OF A HIGH AND LOW ANIONIC SOAP FOR THE REMOVAL 
OF OIL-BASED CONTAMINANT 
Table C-1 
 
 
 
  
Dog ID Tx Group Soap Number of Washes* Soap Amount, ml 
1 1 Dawn® 3 360 
2 1 Dawn® 1 120 
3 1 Dawn® 1 120 
4 1 Dawn® 1 120 
5 1 Dawn® 1 120 
6 2 DermaLyte® 2 240 
7 2 DermaLyte® 3 360 
8 2 DermaLyte® 2 240 
9 2 DermaLyte® 3 360 
10 2 DermaLyte® 2 240 
 50 
 
APPENDIX D 
 
DAILY DERMATOLOGICAL SUMMARY SCORE 
Table D-1 
  Evaluation Days 
Dog Treatment 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
1 DermaLyte® 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 
2 DermaLyte® 0 0 0 0 0 0 0 1 1 1 1 1 2 2 2 
3 DermaLyte® 0 1 1 1 1 1 1 2 2 2 1 2 2 2 2 
4 DermaLyte® 0 0 0 0 0 0 0 1 1 2 1 3 2 2 1 
5 DermaLyte® 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 
6 DermaLyte® 0 0 0 0 0 0 0 1 0 1 1 1 1 1 1 
7 DermaLyte® 0 0 0 0 0 1 1 2 2 2 1 1 1 1 1 
8 DermaLyte® 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
9 DermaLyte® 0 0 0 0 0 0 1 0 0 1 1 1 1 1 1 
10 DermaLyte® 0 0 0 0 0 0 1 1 0 2 1 1 1 1 1 
1 Dawn®  0 0 0 0 0 0 0 1 1 1 2 2 1 1 1 
2 Dawn®  0 0 1 1 1 1 1 1 1 1 1 1 2 2 2 
3 Dawn®  0 0 0 0 0 0 1 2 2 2 1 1 1 1 1 
4 Dawn®  0 0 0 0 0 0 1 2 1 1 2 2 3 4 4 
5 Dawn®  0 0 0 0 0 0 0 1 0 1 1 1 1 1 2 
6 Dawn®  0 0 0 0 0 0 0 0 1 2 2 2 2 2 3 
7 Dawn®  0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 
8 Dawn®  0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 
9 Dawn®  0 0 0 0 0 0 0 1 1 1 2 1 1 1 2 
10 Dawn®  0 0 0 0 0 0 1 2 1 1 1 1 2 2 2 
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APPENDIX E 
 
RELATIVE DAILY RISK BY LOCATION &MEDIAN TEWL RISK DIFFERENCE 
BETWEEN LOCATION TREATMENT GROUPS 
 
Figure E-1: Head median relative daily risks for TEWL 
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Figure E-2: Neck median relative daily risks for TEWL 
 
 
Figure E-3: Right Front Limb median relative daily risks for TEWL 
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Figure E-4: Left Front Limb median relative daily risks for TEWL 
 
 
Figure E-5: Right Axilla median relative daily risks for TEWL 
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Figure E-6: Left Axilla median relative daily risks for TEWL 
 
 
Figure E-7: Sternum median relative daily risks for TEWL 
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Figure E-8: Thorax Right Lateral median relative daily risks for TEWL 
 
 
Figure E-9: Thorax Left Lateral median relative daily risks for TEWL 
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Figure E-10: Thorax Dorsal median relative daily risks for TEWL 
 
 
Figure E-11: Abdomen median relative daily risks for TEWL 
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Figure E-12: Lumbar median relative daily risks for TEWL 
 
 
Figure E-13: Right inguinal median relative daily risks for TEWL 
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Figure E-14: Left inguinal median relative daily risks for TEWL 
 
  
Figure E-15: Left inguinal median relative daily risks for TEWL 
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Figure E-16: Right back limb median relative daily risks for TEWL 
 
 
Figure E-17: Left back limb median relative daily risks for TEWL 
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Figure E-18: Right flank median relative daily risks for TEWL 
 
 
Figure E-19: Tail median relative daily risks for TEWL 
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Table E-1: Median TEWL relative risk between locations treatment groups 
 Head Neck Right Front Limb 
Day Median 95 % CI Median 95 % CI Median 95 % CI 
0 0.8448 0.6381-1.127 1.03 0.8063-1.299 0.835 0.6059-1.162 
1 1.037 0.8344-1.298 0.974 0.7993-1.17 1.264 0.9887-1.585 
2 1.138 0.9017-1.45 1.168 0.9755-1.409 1.415 1.145-1.781 
3 1.141 0.9429-1.387 1.027 0.8678-1.22 1.298 1.056-1.599 
4 1.023 0.8404-1.253 0.945 0.7868-1.129 1.21 0.9794-1.505 
5 0.885 0.7188-1.085 0.842 0.708-0.9985 1.106 0.8946-1.381 
6 1.153 0.9354-1.415 0.978 0.8071-1.167 1.006 0.8114-1.242 
7 1.35 1.098-1.693 1.26 1.051-1.528 0.988 0.795-1.228 
8 1.261 1.038-1.547 1.179 0.9855-1.418 0.826 0.6604-1.009 
9 1.059 0.8686-1.298 1.192 0.9863-1.456 0.849 0.6747-1.067 
10 0.8056 0.6423-1.001 0.723 0.5897-0.8749 0.911 0.7322-1.16 
11 0.8664 0.7103-1.058 0.789 0.6585-0.942 0.762 0.6072-0.9408 
12 0.8658 0.7075-1.052 0.918 0.7689-1.1 0.799 0.6353-0.9924 
13 0.8843 0.7189-1.089 1.173 0.9754-1.421 0.934 0.7476-1.191 
14 0.7379 0.5896-0.9118 1.014 0.8388-1.231 0.894 0.6988-1.165 
 
Table E-1 continued  
 Left Front Limb Right Axilla Left Axilla 
Day Median 95 % CI Median 95 % CI Median 95 % CI 
0 1.165 0.8473-1.607 0.8912 0.8063-1.299 1.012 0.7505-1.395 
1 1.044 0.828-1.324 1.174 0.7993-1.17 1.079 0.8746-1.333 
2 1.121 0.9221-1.398 1.139 0.9755-1.409 0.865 0.7048-1.052 
3 1.011 0.8267-1.236 1.074 0.8678-1.22 0.869 0.7074-1.05 
4 1.002 0.8264-1.218 0.8905 0.7868-1.129 0.965 0.7952-1.16 
5 0.9508 0.7766-1.157 0.9967 0.708-0.9985 1.084 0.8978-1.317 
6 1.002 0.8264-1.209 0.9547 0.8071-1.167 0.897 0.7193-1.09 
7 1.123 0.9266-1.383 1.069 1.051-1.528 1.296 1.069-1.563 
8 0.9964 0.8201-1.209 0.9807 0.9855-1.418 1.155 0.9611-1.395 
9 0.9239 0.7523-1.122 0.932 0.9863-1.456 0.962 0.7906-1.161 
10 0.9584 0.7829-1.185 0.9385 0.5897-0.8749 0.864 0.7001-1.056 
11 0.9215 0.7528-1.122 0.8866 0.6585-0.942 0.853 0.6948-1.037 
12 0.8942 0.7004-1.116 0.9234 0.7689-1.1 1.03 0.8547-1.25 
13 1.027 0.8345-1.276 1.016 0.9754-1.421 1.019 0.8303-1.231 
14 1.053 0.8219-1.349 1.066 0.8388-1.231 1.198 0.972-1.48 
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Table E-1 continued 
 Sternum Thorax Right Lateral Thorax Left Lateral  
Day Median 95 % CI Median 95 % CI Median 95 % CI 
0 1.102 0.807-1.517 1.204 0.8063-1.299 0.886 0.6245-1.264 
1 1.015 0.824-1.256 1.272 0.7993-1.17 1.236 0.9592-1.583 
2 0.9567 0.7824-1.16 1.019 0.9755-1.409 1.033 0.8176-1.311 
3 1.067 0.8939-1.278 1.002 0.8678-1.22 1.017 0.8167-1.27 
4 1.001 0.8339-1.19 1.008 0.7868-1.129 0.918 0.731-1.143 
5 1.021 0.8512-1.221 0.9842 0.708-0.9985 0.957 0.7696-1.181 
6 1.06 0.8834-1.265 0.966 0.8071-1.167 1.035 0.8168-1.312 
7 0.9702 0.7939-1.165 1.094 1.051-1.528 1.111 0.9008-1.391 
8 0.9707 0.7992-1.169 0.9944 0.9855-1.418 1.013 0.8043-1.277 
9 0.9916 0.8256-1.192 1.042 0.9863-1.456 1.076 0.8568-1.37 
10 1.022 0.8556-1.241 0.83 0.5897-0.8749 0.924 0.7329-1.16 
11 0.8247 0.6705-0.9831 0.7224 0.6585-0.942 0.878 0.6855-1.098 
12 0.8842 0.7276-1.052 0.8464 0.7689-1.1 0.894 0.7038-1.139 
13 1.003 0.8274-1.201 1.096 0.9754-1.421 0.904 0.7173-1.118 
14 1.296 1.05-1.645 1.271 0.8388-1.231 1.077 0.8341-1.395 
 
Table E-1 continued 
 Thorax Dorsal Abdomen   Lumbar 
Day Median 95 % CI Median 95 % CI Median 95 % CI 
0 0.7202 0.547-0.9655 1.147 0.8063-1.299 1.026 0.7601-1.372 
1 0.9555 0.7737-1.183 1.006 0.7993-1.17 1.043 0.8285-1.31 
2 1.247 0.9902-1.572 0.9559 0.9755-1.409 0.974 0.7867-1.194 
3 1.256 1.028-1.535 0.9093 0.8678-1.22 0.955 0.7789-1.155 
4 1.248 1.023-1.534 0.8991 0.7868-1.129 1.01 0.8267-1.228 
5 0.9963 0.8197-1.219 0.9658 0.708-0.9985 1.019 0.8345-1.249 
6 1.116 0.9128-1.361 1.028 0.8071-1.167 1.235 1.014-1.502 
7 1.298 1.058-1.602 0.9728 1.051-1.528 1.153 0.9506-1.4 
8 1.135 0.9284-1.392 1.004 0.9855-1.418 1.02 0.8322-1.258 
9 0.8019 0.6496-0.9797 0.9722 0.9863-1.456 1.143 0.9277-1.418 
10 0.8507 0.6759-1.062 1.082 0.5897-0.8749 0.725 0.5712-0.9024 
11 0.7624 0.6214-0.9359 1.058 0.6585-0.942 0.829 0.6675-1.016 
12 0.8585 0.705-1.051 1.04 0.7689-1.1 0.86 0.6911-1.069 
13 0.7172 0.5751-0.8744 1.068 0.9754-1.421 1.005 0.822-1.244 
14 1.022 0.8211-1.282 1.062 0.8388-1.231 1.163 0.9359-1.461 
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Table E-1 continued 
 Right Inguinal Left Inguinal Right Back Leg 
Day Median 95 % CI Median 95 % CI Median 95 % CI 
0 1.111 0.7946-1.576 1.414 0.8063-1.299 1.189 0.7964-1.745 
1 0.9452 0.7486-1.212 0.9845 0.7993-1.17 1.002 0.7792-1.275 
2 0.8403 0.6576-1.044 1.021 0.9755-1.409 0.918 0.7275-1.14 
3 0.9876 0.8019-1.225 0.892 0.8678-1.22 0.945 0.755-1.162 
4 0.9533 0.7714-1.184 0.9123 0.7868-1.129 1.051 0.849-1.308 
5 0.94 0.7645-1.155 0.9 0.708-0.9985 1.114 0.8999-1.419 
6 0.9692 0.7665-1.205 0.8895 0.8071-1.167 1.001 0.7976-1.251 
7 1.015 0.8227-1.248 0.9622 1.051-1.528 1.089 0.8587-1.403 
8 0.9864 0.7941-1.219 0.9513 0.9855-1.418 1.007 0.8052-1.267 
9 1.107 0.9067-1.387 1.054 0.9863-1.456 0.958 0.7469-1.215 
10 1.052 0.8379-1.3 1.283 0.5897-0.8749 0.971 0.77-1.216 
11 1.158 0.9466-1.428 1.114 0.6585-0.942 0.993 0.7783-1.272 
12 1.239 1.005-1.555 1.116 0.7689-1.1 0.944 0.7301-1.193 
13 0.9797 0.7748-1.213 0.9703 0.9754-1.421 0.918 0.7193-1.145 
14 0.8978 0.7047-1.146 1.025 0.8388-1.231 1.118 0.8615-1.471 
 
Table E-1 continued 
 Left Back Limb Right Flank Left Flank 
Day Median 95 % CI Median 95 % CI Median 95 % CI 
0 0.9147 0.6508-1.283 1.204 0.8063-1.299 1.01 0.7041-1.45 
1 1.089 0.8188-1.437 1.086 0.7993-1.17 0.823 0.6569-1.024 
2 1.01 0.7689-1.324 1.01 0.9755-1.409 0.893 0.7399-1.073 
3 0.9806 0.7513-1.27 0.9722 0.8678-1.22 1.015 0.8488-1.218 
4 1 0.7667-1.306 0.9895 0.7868-1.129 1.044 0.8761-1.245 
5 1.177 0.909-1.547 1.044 0.708-0.9985 1.035 0.8676-1.227 
6 1.351 1.041-1.788 1.061 0.8071-1.167 1.06 0.8955-1.281 
7 1.251 0.9681-1.631 1.042 1.051-1.528 0.979 0.814-1.17 
8 1.064 0.8245-1.384 1.073 0.9855-1.418 0.921 0.7619-1.091 
9 1.165 0.8874-1.542 1.023 0.9863-1.456 0.925 0.7669-1.101 
10 0.9763 0.7376-1.303 0.8902 0.5897-0.8749 0.908 0.7471-1.077 
11 0.5744 0.4536-0.7439 0.925 0.6585-0.942 1.037 0.8644-1.24 
12 1.053 0.7917-1.43 0.9283 0.7689-1.1 1.13 0.9507-1.37 
13 0.5845 0.4427-0.756 0.9629 0.9754-1.421 1.18 0.9851-1.446 
14 1.077 0.7958-1.49 1.016 0.8388-1.231 1.119 0.9038-1.396 
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Table E-1 continued 
 Tail 
Day Median 95 % CI 
0 1.483 1.12-1.985 
1 1.268 1.028-1.593 
2 1.073 0.8889-1.273 
3 1.094 0.9099-1.309 
4 1.016 0.8512-1.205 
5 1.068 0.9012-1.285 
6 0.9692 0.8041-1.146 
7 1.145 0.9617-1.361 
8 1.186 0.9954-1.433 
9 1.13 0.9437-1.365 
10 0.9032 0.7519-1.083 
11 0.7667 0.628-0.9257 
12 0.8572 0.706-1.043 
13 0.8013 0.654-0.9628 
14 0.8773 0.7057-1.086 
 
